Eighty-two healthy , HIV uninfected , South African adults , with a BCG scar and tuberculin skin test ( TST ) diameter @ mm , were randomized to receive @ months of INH , starting either before , or @ months after , intradermal revaccination with BCG Vaccine SSI ( Statens Serum Institut , Copenhagen ) .